New Evidence Highlights Risks of Cannabis Use During Pregnancy

A comprehensive systematic review and meta-analysis have raised significant concerns about the use of cannabis during pregnancy. The research, conducted by scientists at Oregon Health & Science University and published in JAMA Pediatrics, suggests that prenatal cannabis exposure is associated with increased risks of adverse neonatal outcomes. These include higher chances of preterm birth, low birth weight, and infants being small for their gestational age. The study analyzed data from 51 observational studies involving over 21 million individuals, incorporating eight new studies into the latest review. The findings indicate a moderate level of evidence linking prenatal cannabis use to these adverse outcomes, and also suggest increased neonatal mortality, though this carries lower certainty.
Cannabis remains one of the most commonly used substances during pregnancy despite it being illegal under federal law in the United States. Many pregnant women perceive cannabis as relatively safe, especially since it can alleviate common pregnancy symptoms such as nausea, insomnia, and pain. This is a concern for healthcare providers who advise caution due to the growing evidence of potential harm.
Animal studies support these human findings, showing that exposure to THC — the primary psychoactive component of cannabis — can impair placental function, reducing blood flow and oxygen supply, which may hinder fetal development. In humans, imaging studies have demonstrated decreased placental blood flow and reduced amniotic fluid volume in cases of prenatal cannabis use.
Dr. Jamie Lo, an obstetrician specializing in high-risk pregnancies, emphasizes the importance of understanding that cannabis use during pregnancy can negatively impact placental health and fetal growth. Even in states like Oregon, where cannabis is legalized for recreational and medicinal purposes, medical experts recommend harm-reduction strategies. This involves reducing consumption when abstinence is not feasible, as even smaller amounts of cannabis can mitigate some risks.
While the current evidence underscores potential dangers, the authors acknowledge that further research is necessary to establish definitive causal relationships. Nevertheless, healthcare professionals advise pregnant women to avoid cannabis to promote healthier pregnancy outcomes. Public awareness and counseling are vital to reduce prenatal exposure and protect neonatal health.
Source: https://medicalxpress.com/news/2025-05-evidence-cannabis-pregnancy.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Southeast Asia Likely to Miss 2030 Targets for Ending Diseases Despite Progress Challenges
ASEAN countries face significant challenges in achieving health-related Sustainable Development Goals by 2030, with progress hindered by inequalities and weak infrastructure, though some nations show promise. Experts emphasize urgent action to bridge gaps and prevent disease burden escalation.
Enhancing Cancer Outcomes Through Improved Lynch Syndrome Testing: A Cost-Effectiveness Analysis
A comprehensive analysis demonstrates that universal Lynch syndrome testing for colorectal cancer patients significantly enhances early detection and is cost-effective, leading to improved cancer prevention and reduced healthcare costs.
Promising Outcomes from First Prospective Study on Heart Failure in Chagas Disease Patients
A groundbreaking trial at ESC Congress 2025 reveals that sacubitril/valsartan significantly improves outcomes in patients with heart failure caused by Chagas disease, marking a milestone in managing this neglected tropical disease.
Enhanced Cancer Treatment Through Balanced Immunotherapy Targeting Hot Tumors
A new study reveals that balancing the inflammatory response within tumors enhances the effectiveness of immunotherapy, offering improved outcomes for patients with metastatic cancers.